Skip to main content

Common Symptom of Concern-sore Throat usually not caused by new Coronavirus, says Research

Common Symptom of Concern-sore Throat usually not caused by nCOVID, says Research

According to international media BGR report, a new COVID-19 study found that loss of smell and taste is a possible symptom of new coronavirus infection, but also found that sore throat is not necessarily evidence related to the disease. Researchers at the University of California, San Diego found that patients whose symptoms include a sore throat are more likely to be negative for COVID-19. In different countries, sensory disorders are related to COVID-19, and doctors have observed this symptom in many patients. By observing the olfactory tissue, the researchers determined that the SARS-CoV-2 virus can quickly attach itself to specific cells as if it were combined with lung cells.
Representation for  Symptom of Concern-sore Throat is usually not caused by new Coronavirus

Researchers from the University of California San Diego School of Health also determined that patients recovering from COVID-19 can recover their sense of smell and taste within two to four weeks after infection. But they also made another finding, that is, one of the symptoms that may be related to COVID-19. Sore throat does not always point to COVID-19 infection.

Most common symptoms are Fever, cough, shortness of breath, and fatigue

Fever, cough, shortness of breath, and fatigue are the most common symptoms of COVID-19, and the symptoms of loss of smell and taste are not listed here. But a sore throat sounds like a symptom caused by respiratory viruses, and some patients with COVID-19 have indeed experienced this symptom. 
That being said, researchers at the University of California, San Diego found that most of the COVID-19-positive patients they investigated did not show symptoms of sore throat.

    Olfactory and taste disorders are independently and strongly related to COVID-19-positive, while sore throat is related to COVID-19 negative.

Sore throat is associated with Covid-19 negative (60%, compared with 32% in Covid-19 positive patients)

The researchers found that COVID-19-negative patients reported sore throats four to five times more than COVID-19-positive patients. This is particularly relevant because this season people in many parts of the United States begin to develop hay fever; sore throats and congestion are unlikely symptoms of new coronavirus infections.

This study analyzed 1480 patients with suspected flu-like symptoms or suspected infection with COVID-19. Among these people, only 102 people tested positive. The study then included responses from 59 COVID-19 patients and 203 people with other diseases. 
The number of respondents seems limited, but most COVID-19 studies include a limited sample size at this point. 
Unlike other studies that have not been peer-reviewed, the University of California, San Diego has been fully peer-reviewed and awaits final publication at the International Allergy and Rhinology Forum.

Most of the COVID-19 patients in the study were patients with milder disease and did not require oxygen therapy or intubation and ventilation. Most patients do not need to be hospitalized. The researchers concluded that medical professionals should include questions about loss of smell and taste in their COVID-19 screening. This unusual symptom can help them find and isolate patients before the test results come out. 

Global virus screening measure

"We hope that with these findings, other organizations can follow suit and not only list olfactory and taste loss as a symptom of COVID-19, but also use it as a global virus screening measure," Otolaryngologist at the University of California, San Diego and head and neck surgeon Carol Yan told the University of California, San Diego News Center.


Popular posts from this blog

Difference Between COVID-19 Coronavirus and Other Flu Epidemic Infections

What are the differences between COVID-19 and the flu epidemic?The epidemic caused by the new Coronavirus (2019-nCoV) is still spreading. This disease, which has just been officially named COVID-19, has caused more than 40,000 infections and more than 1,000 deaths. At the same time, on the other side of the ocean, another epidemic also attracted people's attention. The flu season in the United States is on schedule. 
According to data released by the US Centers for Disease Control and Prevention, as of February 1, 22 million to 31 million people are expected to be infected during the flu season, and the number of patients dying from influenza is between 12,000 and 30,000. 
Seeing such figures, some readers may be surprised when they think: Is the flu epidemic in the United States worse? What are the differences between COVID-19 and the flu epidemic? Is this really the case? What are the differences between COVID-19 and the flu epidemic?
The facts are being unraveled below: 1. Unknown ris…

FDA Launches New Website to Encourage COVID-19 Rehabilitation Patients to Donate Plasma

According to foreign media TechCrunch, one of the ways currently being sought to develop effective treatments for COVID-19 is to use convalescent plasma. Basically, this means using plasma from COVID-19 patients who have fully recovered, hoping to transfer the antibodies they produced during the fight against the virus to others. 

US Food and Drug Administration (FDA) creates dedicated website to seek recovery plasma donationsThe US Food and Drug Administration (FDA) has created a dedicated new website that seeks recovery plasma donations from COVID-19 rehabilitation patients and explains their potential uses.
The use of plasma during recovery is hardly a new concept. In fact, it has been used since the late 1890s and was used during the Spanish influenza pandemic in 1918, although "the results were mixed."
Modern methods can help improve the efficacy and potential of recovered plasma as a therapeutic method. There are currently some drugs under development that use plasma (ani…

Considerations Before Electrocardiogram ECG Test